research
Home / Career
What the Research Shows
Over the past two decades, psilocybin has been studied in carefully designed clinical research settings. While research is ongoing, studies suggest that when psilocybin is used with preparation, support, and integration, some people experience meaningful psychological and emotional shifts.
Improved mood and emotional flexibility
Reduced anxiety and psychological distress
Greater sense of meaning or perspective
Lasting changes in how people relate to themselves and their lives
how it works
Depression & Emotional Flexibility
Depression
In controlled studies, participants experiencing depression reported noticeable reductions in symptoms following a single supported psilocybin session combined with psychological preparation and integration.
What this suggests:
Psilocybin may help some individuals access new perspectives and emotional flexibility when supported in an intentional setting.
Anxiety & Existential Distress
Studies involving individuals facing serious or life-threatening illness found reductions in anxiety, fear, and emotional distress, with some effects lasting for months.
What this suggests:
Psilocybin may support emotional processing, acceptance, and meaning-making during profound life stress.
Meaning & Well-Being
Research focusing on meaning and purpose found that participants often reported feeling more connected, less isolated, and better able to engage with life.
What this suggests:
For some people, psilocybin experiences may support lasting shifts in perspective beyond symptom relief.
Why Preparation and Integration Matter
Across nearly all studies, researchers emphasize that outcomes depend heavily on context. Psilocybin is studied as part of a process that includes:
- Thoughtful preparation
- A supportive and contained environment
- Skilled, non-directive facilitation
- Intentional integration afterward
Without these elements, experiences may feel confusing, overwhelming, or incomplete.
Specific Research & Clinical Evidence
Psilocybin-assisted therapy has been studied in controlled clinical settings for over two decades. While research is ongoing, a growing body of peer-reviewed evidence suggests that psilocybin, when used in structured and supportive contexts, may support meaningful psychological and existential change.
Psilocybin for Major Depressive Disorder
JAMA Psychiatry (2023)
A randomized, placebo-controlled clinical trial examining a single 25 mg dose of psilocybin in adults with major depressive disorder. The study found psilocybin to be well tolerated and associated with reductions in depressive symptoms under controlled conditions.
Reductions in Existential Distress and Suicidal Ideation
Journal of Psychopharmacology / PMC
This study found significant and sustained reductions in existential distress, loss of meaning, and suicidal ideation in individuals with advanced cancer.
Ongoing Clinical Trials and Future Research
Psilocybin-assisted therapy continues to be studied in Phase II and Phase III clinical trials,
including research on depression, anxiety, and existential distress in medical and psychiatric
populations
Psilocybin for Anxiety and Depression in Cancer Patients
Rapid and Sustained Symptom Reduction Following Psilocybin Treatment for Anxiety and Depression in Patients With Life-Threatening Cancer
Journal of Psychopharmacology (2016)
This double-blind, crossover study demonstrated rapid and sustained reductions in anxiety, depression, hopelessness, and existential distress.
Review of Psilocybin Across Clinical Indications
A Systematic Review and Meta-Analysis
A comprehensive review highlighting consistency and durability of outcomes when psilocybin is combined with structured psychological support.